支气管镜诊断率评估:临床/影像因素、操作类型及癌症怀疑度的影响
本研究为前瞻性多中心试验的二次数据分析,纳入687例患者,评估标准支气管镜、EBUS-TBNA、电磁导航及联合操作的诊断率。总体诊断率为69%,EBUS最高(80%),医师癌症怀疑概率(pCA)<10%和10%-60%者诊断率较低(44%和42%),pCA>60%者为77%。EBUS-TBNA、较大病灶和中心位置与诊断性支气管镜独立相关。
要点
- 总体诊断率69%,EBUS-TBNA最高(80%),标准支气管镜活检±透视最低(55%)。
- 医师癌症怀疑概率(pCA)<10%和10%-60%诊断率分别为44%和42%,pCA>60%为77%。
- EBUS-TBNA、较大病灶和中心位置是多变量分析中与诊断性支气管镜显著相关的因素。
核心结论
- 支气管镜诊断率随医师癌症怀疑概率、患者临床/影像特征及操作类型变化很大。
- 在所用操作中,EBUS-TBNA最可能提供诊断。
研究设计与样本
- 前瞻性多中心试验的二次数据分析,纳入28个中心的687例患者。
- 评估标准支气管镜活检±透视、EBUS-TBNA、电磁导航及联合操作的诊断率,诊断与非诊断标准预先严格定义。
主要发现
- 总体诊断率69%;EBUS为80%,标准支气管镜活检±透视55%,电磁导航57%,联合操作74%(P < .001)。
- pCA < 10%和10%-60%诊断率分别为44%和42%,pCA > 60%为77%(P < .001)。
- 多变量logistic回归显示EBUS-TBNA、较大病灶和中心位置与诊断性支气管镜显著相关。
关键数值与推荐
- 诊断率:总体69%,EBUS 80%,标准支气管镜活检±透视55%,电磁导航57%,联合操作74%(P < .001)。
- 按pCA分层诊断率:<10%为44%,10%-60%为42%,>60%为77%(P < .001)。
临床怎么用
- 医师术前评估癌症概率(pCA)有助于预判支气管镜诊断率并选择操作方式。
- 对pCA较低者需考虑诊断率有限,可能需规划二次操作。
- EBUS-TBNA在可用时应优先考虑以提高诊断率。
局限性
- 本研究为二次数据分析。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bronchoscopy is commonly used to evaluate suspicious lung lesions. The yield is likely dependent on patient, radiographic, and bronchoscopic factors. Few studies have assessed these factors simultaneously while also including the preprocedure physician-assessed probability of cancer (pCA) when assessing yield. METHODS: This study is a secondary data analysis from a prospective multicenter trial. Diagnostic yield of standard bronchoscopy with biopsy ± fluoroscopy, endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA), electromagnetic navigation, and combination bronchoscopies was assessed. Definitions for diagnostic and nondiagnostic bronchoscopies were rigorously predefined. The association of diagnostic yield with individual variables was examined by using univariate and multivariate logistic regression analyses where appropriate. RESULTS: A total of 687 patients were included from 28 sites. Overall diagnostic yield was 69%; 80% for EBUS, 55% for bronchoscopy with biopsy ± fluoroscopy, 57% for electromagnetic navigation, and 74% for combination procedures (P < .001). Patients with larger, central lesions with adenopathy were significantly more likely to undergo a diagnostic bronchoscopy. Patients with pCA < 10% and 10% to 60% had lower yields (44% and 42%, respectively), whereas pCA > 60% yielded a positive result in 77% (P < .001). In multivariate logistic regression, the use of EBUS-TBNA, larger sized lesions, and central location were significantly associated with a diagnostic bronchoscopy. Seventeen percent of those with a malignant diagnosis and 28% of those with a benign diagnosis required secondary procedures to establish a diagnosis. CONCLUSIONS: This study is the first to assess the yield of bronchoscopy according to physician-assessed pCA in a large, prospective multicenter trial. The yield of bronchoscopy varied greatly according to physician suspicion that cancer is present, the patients' clinical/radiographic features, and the type of procedure performed. Of the procedures performed, EBUS-TBNA was the most likely to provide a diagnosis.
引用
- Silvestri GA, Bevill BT, Huang J, et al. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020. PMID: 31978428. doi:10.1016/j.chest.2019.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。